Prof Marie-Aleth Richard is an expert in Dermatology at Hôpital de la Timone (France). As of October 2026, ScienceLeadR ranks Marie-Aleth Richard in the top 1% of experts worldwide for Sexually Transmitted Diseases, Psoriasis and Dermatitis. Marie-Aleth Richard has authored 634 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 6 of them ongoing. SLR score: 1,933 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Marie-Aleth Richard Hôpital de la Timone France
1 933 ScienceLeadR Reputation 1933
Network Map

Dermatology

Subspecialties: Infectiology - Public Health - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1986 - 2026

Source: PubMed

Hôpital de la Timone

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Global Disparities in Access to Dermatological Care.
PMID 42646828 — skin, income, skin diseases, dermatologists, dermatology, workforce
JAMA Dermatol20261
Beyond the numbers: Understanding and acting on gender gaps in academic dermatology.
PMID 42535515 — sexually transmitted diseases, skin diseases, dermatology
J Eur Acad Dermatol Venereol20260
Real-world Clinical Effectiveness of Guselkumab and Its Impact on Quality of Life and Sexual Quality of Life in Patients with Genital Psoriasis: Results from the CASSIOPEE Study.
PMID 42478139 — quality of life, syphilis, psoriasis, dermatology
Br J Dermatol20260
A case of bullous fixed drug eruption induced by tenofovir disoproxil fumarate/ emtricitabine.
PMID 42127743 — sexually transmitted diseases, tenofovir, pharmaceutical preparations, fumarates, emtricitabine, drug eruptions, dermatology
Ann Dermatol Venereol20260
Use of social media and alternative and complementary medicine in a cohort of 1053 patients with hidradenitis suppurativa.
PMID 42127745 — sexually transmitted diseases, hidradenitis suppurativa, social media, hidradenitis, dermatology
Ann Dermatol Venereol20260

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

Phase 3 9
N/A 4
Phase 2 2
Phase 2/Phase 3 2
Phase 1 1
Phase 4 1

By status:

Completed 9
Recruiting 5
Not yet recruiting 2
Unknown 2
Active not recruiting 1

By type:

Interventional 17
Observational 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 3
multicentric5to9 2
multicentricup10 12

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
FEcal tranSplantation in HidradeniTIs suppuratiVA a piLot Study
NCT07668713 — pilot projects, pilots, fecal microbiota transplantation, hidradenitis suppurativa, hidradenitis, therapeutics, transplantation, microbiota
Phase 1Not yet recruiting2026
Involvement of Pollutants in Atopic Dermatitis and Psoriasis
NCT06213688 — cytokines, cells, receptors, aryl hydrocarbon, dioxins, t-lymphocytes, regulatory, blood, dermatitis, environmental pollutants, eczema, benzo(a)pyrene, environmental pollution, polycyclic aromatic hydrocarbons, hydrocarbons, psoriasis, hydrocarbons, aromatic, dermatitis, atopic
N/ANot yet recruiting2024
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus
Phase 4Recruiting2024
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
NCT04789850 — sclerosis, safety, scleroderma, systemic
Phase 2Recruiting2023
Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
NCT04227314 — stomatitis, aphthous, safety, tablets, stomatitis, therapeutics
Phase 3Recruiting2022

LeadR Networks

Main global connection map